0002104142-26-000001.txt : 20260113 0002104142-26-000001.hdr.sgml : 20260113 20260113121643 ACCESSION NUMBER: 0002104142-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260113 DATE AS OF CHANGE: 20260113 EFFECTIVENESS DATE: 20260113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABLi Therapeutics, Inc. CENTRAL INDEX KEY: 0002104142 ORGANIZATION NAME: EIN: 332622009 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-569754 FILM NUMBER: 26529132 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PKWY SE STREET 2: STE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 9174940831 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PKWY SE STREET 2: STE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 D 1 primary_doc.xml X0708 D LIVE 0002104142 ABLi Therapeutics, Inc. 3350 RIVERWOOD PKWY SE STE 1900 ATLANTA GA GEORGIA 30339 917-494-0831 DELAWARE None None Corporation true 2025 Milton H. Werner 3350 Riverwood Parkway SE Suite 1900 Atlanta GA GEORGIA 30339 Executive Officer Director Chief Executive Officer, President, and Secretary Garth Lees-Rolfe 3350 Riverwood Parkway SE Suite 1900 Atlanta GA GEORGIA 30339 Executive Officer Chief Financial Officer and Treasurer Anastasia Daifotis 3350 Riverwood Parkway SE Suite 1900 Atlanta GA GEORGIA 30339 Director Jeffrey Young 3350 Riverwood Parkway SE Suite 1900 Atlanta GA GEORGIA 30339 Director Pharmaceuticals Decline to Disclose 06b false 2025-09-15 false true false 0 1000000 1000000 0 false 10 0 0 0 false ABLi Therapeutics, Inc. /s/ Milton H. Werner, PhD Milton H. Werner, PhD Chief Executive Officer 2026-01-13